龙芯中科(688047) - 2025 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2025 was ¥124,955,396.95, representing a 4.13% increase compared to ¥119,997,881.69 in the same period last year[3] - The net profit attributable to shareholders was -¥151,280,445.14, a significant decline from -¥74,808,468.70 year-on-year[3] - Total operating revenue for Q1 2025 was CNY 124,955,396.95, an increase of 4.0% compared to CNY 119,997,881.69 in Q1 2024[16] - Net loss for Q1 2025 was CNY -151,280,445.14, compared to a net loss of CNY -74,808,468.70 in Q1 2024, representing a deterioration of 102.0%[17] - Basic and diluted earnings per share for Q1 2025 were both CNY -0.38, compared to CNY -0.19 in Q1 2024[17] Research and Development - Research and development (R&D) expenses totaled ¥134,952,519.79, marking a 35.22% increase from ¥99,803,642.73 in the previous year[3] - The ratio of R&D expenses to operating revenue increased by 24.83 percentage points to 108.00%[4] - R&D expenses in Q1 2025 reached CNY 122,346,703.13, a significant increase of 44.6% compared to CNY 84,575,382.20 in Q1 2024[16] - The company reported development expenditures of CNY 130,817,379.03, an increase from CNY 118,211,562.37, indicating a growth of approximately 11%[12] - The company continues to focus on R&D and market expansion strategies despite the financial losses reported[16] Cash Flow and Liquidity - The net cash flow from operating activities was -¥143,594,192.40, a substantial decrease from -¥8,728,297.90 in the previous year[3] - In Q1 2025, the cash inflow from operating activities was $127,233,539.39, a decrease of 46.8% compared to $239,153,280.38 in Q1 2024[19] - The net cash flow from operating activities in Q1 2025 was -$143,594,192.40, worsening from -$8,728,297.90 in Q1 2024[19] - The cash outflow from financing activities in Q1 2025 was $1,045,030.59, compared to $99,733,198.82 in Q1 2024, indicating a reduction in financing outflows[20] - The ending balance of cash and cash equivalents as of Q1 2025 was $298,335,490.02, down from $494,824,167.21 in Q1 2024[20] Assets and Liabilities - Total assets at the end of the reporting period were ¥3,307,606,193.04, down 5.43% from ¥3,497,483,392.20 at the end of the previous year[4] - Total liabilities decreased to CNY 516,521,637.74 from CNY 561,086,316.99, a reduction of 7.9%[14] - The equity attributable to shareholders decreased by 4.95% to ¥2,791,084,555.30 from ¥2,936,397,075.21[4] - Total equity attributable to shareholders decreased to CNY 2,791,084,555.30 from CNY 2,936,397,075.21, a decline of 4.9%[14] Shareholder Information - The total number of common shareholders at the end of the reporting period was 18,322[8] - The company has no significant changes in the top 10 shareholders or their participation in margin trading[10] Operational Status - The company has not disclosed any new strategies or market expansions during the reporting period[11] - There are no significant reminders or additional important information regarding the company's operational status during the reporting period[11] - The company did not report any new product developments or market expansions during the conference call[21] Sales and Costs - Total operating costs for Q1 2025 were CNY 245,292,507.98, up 17.0% from CNY 209,571,643.10 in Q1 2024[16] - The company reported a significant decrease in cash received from sales of goods and services, totaling $104,053,571.87 in Q1 2025, compared to $140,020,130.89 in Q1 2024, a decline of 25.7%[19] - The cash paid for goods and services in Q1 2025 was $123,261,994.63, an increase from $93,026,108.47 in Q1 2024, reflecting a rise of 32.5%[19]